| scholarly article | Q13442814 |
| P50 | author | Vanesa Balboa Barreiro | Q56738576 |
| Cristina Gonzalez-Martin | Q90002572 | ||
| Raquel Veiga-Seijo | Q90002576 | ||
| P2093 | author name string | Sonia Pertega-Diaz | |
| Silvia Grande Morais | |||
| Teresa Seoane-Pillado | |||
| P2860 | cites work | A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 |
| Cardiovascular Disease Risk in Patients with Rheumatic Diseases | Q30240680 | ||
| Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms | Q30250110 | ||
| Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project | Q30968522 | ||
| Lipid and lipoprotein levels and trend in rheumatoid arthritis compared to the general population | Q33765761 | ||
| Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review | Q34244819 | ||
| Cardiovascular risk in psoriatic arthritis - a cross-sectional study | Q34717077 | ||
| Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies. | Q35998182 | ||
| Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis | Q36098818 | ||
| Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. | Q50552445 | ||
| Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. | Q51126183 | ||
| Cardiovascular morbidity in psoriatic arthritis | Q60699917 | ||
| Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 | ||
| [Cardiovascular risk factors and Primary Care: evaluation and intervention] | Q82592377 | ||
| ??? | Q22242898 | ||
| Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach. | Q36347651 | ||
| Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis | Q36464352 | ||
| Cardiovascular co-morbidity in rheumatic diseases | Q36835851 | ||
| Hypertension in rheumatoid arthritis. | Q37158219 | ||
| Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases | Q37385755 | ||
| Cardiovascular co-morbidity in early rheumatoid arthritis. | Q37398086 | ||
| Spondyloarthropathies: an independent cardiovascular risk factor? | Q37774455 | ||
| Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis | Q37790040 | ||
| Obesity in rheumatoid arthritis | Q37801496 | ||
| Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives | Q37812524 | ||
| Mortality and causes of death in psoriatic arthritis | Q38023166 | ||
| Inflammatory arthritis as a novel risk factor for cardiovascular disease | Q38030254 | ||
| Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. | Q38058361 | ||
| Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. | Q38081282 | ||
| Current concepts in psoriatic arthritis: pathogenesis and management | Q38191427 | ||
| Recognizing and managing comorbidities in psoriatic arthritis | Q38324959 | ||
| Cardiovascular comorbidity in rheumatic diseases | Q38568465 | ||
| Comorbidities in Psoriatic Arthritis | Q38609833 | ||
| Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders | Q38738136 | ||
| Metabolic abnormalities in patients with inflammatory rheumatic diseases | Q38783277 | ||
| The role of non-invasive cardiovascular imaging in the assessment of cardiovascular risk in rheumatoid arthritis: where we are and where we need to be. | Q38789725 | ||
| Cardiovascular risk in patients with rheumatoid arthritis | Q38813397 | ||
| Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis | Q38951238 | ||
| Cardiovascular disease in inflammatory rheumatic diseases | Q39037783 | ||
| Cardiometabolic Disorders in Psoriatic Disease | Q40069191 | ||
| A computer tool for cardiovascular risk estimation according to Framingham and SCORE equations | Q43742488 | ||
| Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. | Q46003173 | ||
| Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China | Q47940789 | ||
| Inflammatory Arthritis and Heart Disease | Q49850393 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 7689208 | |
| P577 | publication date | 2019-03-14 | |
| P1433 | published in | Cardiology Research and Practice | Q26853980 |
| P1476 | title | Concordance between the Different Cardiovascular Risk Scores in People with Rheumatoid Arthritis and Psoriasis Arthritis | |
| P478 | volume | 2019 |
Search more.